DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Maddocks KJ, Ruppert AS, Lozanski G, Heerema NA, Zhao W, Abruzzo L. et al.
Etiology of ibrutinib therapy discontinuation and outcomes in patients with chronic lymphocytic leukemia.
JAMA Oncol 2015;
1: 80-7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.